期刊文献+

乳腺癌的风险评估及治疗 被引量:1

Risk Assessment and Treatment of Breast Cancer
下载PDF
导出
摘要 乳腺癌是一个与日俱增的公共健康问题。近年来实质性的治疗乳腺癌的方法已有一定进展,但是女性逐渐升高的患病风险以及治疗的困难性说明现有的乳腺癌的风险评估方法已经不太适用。引进新的途径对近期数据进行风险预测,并用于治疗已是形势所趋。综述了乳腺癌的风险预测模型、风险评估指征以及乳腺癌的治疗方法。 Breast cancer is becoming a public health problem. Substantial progress has been made in thetreatment of breast cancer,but in recent years,the increased risk of women and the difficulty of treatmentillustrate the present risk assessment methods are not applicable. Therefore,the introduction of new ap-proaches for risk prediction,and for treatment have become the trend. This paper reviewed the risk predic-tion model,the risk assessment,and the treatment of breast cancer.
出处 《江汉大学学报(自然科学版)》 2016年第2期179-183,共5页 Journal of Jianghan University:Natural Science Edition
基金 国家自然科学基金资助项目(30870981 812727754 81470110) 湖北省卫生和计划生育委员会基金资助项目(WJ2015Z059) 江汉大学学生科研资助项目(2015yb254)
关键词 乳腺癌 风险评估 治疗 breast cancer risk assessment treatment
  • 相关文献

参考文献57

  • 1ECCLES S A, ABOAGYE E O, ALI S, et al. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer[J] . Breast Cancer Res, 2013,15 (5) : R92.
  • 2ARNOLD M, KARIM-KOS H E, COEBERGH J W, et al. Recent trends in incidence of five common cancers in 26 European countries since 1988 : analysis of the European Cancer Observatory [J]. Eur J Cancer, 2013,56(2) :289-310.
  • 3RAHIB L, SMITH B D, AIZENBERG R, et al. Projecting cancer incidence and deaths to 2030 : the unexpected burden of thy- roid, liver, and pancreas cancers in the United States [ J ]. Cancer Res, 2014,74 ( 11 ) : 2913-2921.
  • 4COLDITZ G A, BOHLKE K. Priorities for the primary prevention of breast cancer [ J ]. CA Cancer J Clin, 2014,64 (3) : 186-194.
  • 5TRYGGVADOTrIR L, SIGVALDASON H, OLAFSDOTrIR G H, et al. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000 [J 3. J Nail Cancer Inst, 2006,98 (2) : 116-122.
  • 6SLATTERY M L , JOHN E M, TORRES-MEJIA G, et at. Genetic variation in genes involved in hormones, inflammation and ener- getic factors and breast cancer risk in an admixed population [ J ]. Carcinogenesis, 2012,33 ( 8 ) : 1512-1521.
  • 7CUZICK J, SESTAK I, BONANNI B, et al. Selective oestrogen receptor modulators in prevention of breast cancer : an updated recta-analysis of individual participant data [J ]. Lancet, 2013,381 ( 13 ) : 1827-1834.
  • 8GOSS P E, INGLE J N, ALES-MARTINEZ J E, et alExemestane for breast cancer prevention in postmenopausal women [J]. N Engl J Med,2011,64(25) :2381-2391.
  • 9CUZICK J, SESTAK I, FORBES J F, et al. IBIS-II investigators : anastrozole for prevention of breast cancer in high-risk post- menopausal women (IBIS-II) : an international, double-blind, randomised placebo-controlled trial [J]. Lancet, 2014, 383 (9922) : 1041-1048.
  • 10BROWN P. Prevention : targeted therapy-anastrozole prevents breast cancer [ J ]. Nat Rev Clin Oncol, 2014,11 ( 3 ) : 127-128.

同被引文献11

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部